$AKBA
Akebia Therapeutics, Inc.

2017 Q3 Form 10-Q Financial Statement

#000156459017022727 Filed on November 08, 2017

View on sec.gov

Income Statement

Concept 2017 Q3 2016 Q3
Revenue $41.28M $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.700M $4.900M
YoY Change 36.73% 25.64%
% of Gross Profit
Research & Development $58.70M $31.24M
YoY Change 87.91% 97.71%
% of Gross Profit
Depreciation & Amortization $200.0K $100.0K
YoY Change 100.0% 150.0%
% of Gross Profit
Operating Expenses $65.46M $36.18M
YoY Change 80.92% 83.87%
Operating Profit -$24.18M -$36.18M
YoY Change -33.18% 83.87%
Interest Expense $842.0K $200.0K
YoY Change 321.0% 100.0%
% of Operating Profit
Other Income/Expense, Net $1.042M -$126.0K
YoY Change -926.98% -162.07%
Pretax Income -$23.10M -$36.30M
YoY Change -36.36% 86.15%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$23.13M -$36.31M
YoY Change -36.28% 86.43%
Net Earnings / Revenue -56.04%
Basic Earnings Per Share -$0.49
Diluted Earnings Per Share -$0.49 -$957.8K
COMMON SHARES
Basic Shares Outstanding 46.94M
Diluted Shares Outstanding 46.94M

Balance Sheet

Concept 2017 Q3 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $307.0M $144.6M
YoY Change 112.26% -8.16%
Cash & Equivalents $89.60M $65.83M
Short-Term Investments $217.4M $78.82M
Other Short-Term Assets $4.000M $3.800M
YoY Change 5.26% 192.31%
Inventory
Prepaid Expenses
Receivables $300.0K
Other Receivables $0.00
Total Short-Term Assets $333.9M $165.1M
YoY Change 102.24% 3.97%
LONG-TERM ASSETS
Property, Plant & Equipment $3.400M $2.700M
YoY Change 25.93% 440.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.300M $1.300M
YoY Change 0.0% 333.33%
Total Long-Term Assets $4.700M $4.000M
YoY Change 17.5% 400.0%
TOTAL ASSETS
Total Short-Term Assets $333.9M $165.1M
Total Long-Term Assets $4.700M $4.000M
Total Assets $338.6M $169.1M
YoY Change 100.24% 5.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.700M $8.500M
YoY Change 2.35% 60.38%
Accrued Expenses $21.40M $17.60M
YoY Change 21.59% 97.75%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $151.4M $26.10M
YoY Change 480.08% 83.8%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $87.40M $42.30M
YoY Change 106.62%
Total Long-Term Liabilities $87.40M $42.30M
YoY Change 106.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $151.4M $26.10M
Total Long-Term Liabilities $87.40M $42.30M
Total Liabilities $238.7M $68.40M
YoY Change 248.98% 381.69%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $99.90M $100.7M
YoY Change
Total Liabilities & Shareholders Equity $338.6M $169.1M
YoY Change 100.24% 5.95%

Cashflow Statement

Concept 2017 Q3 2016 Q3
OPERATING ACTIVITIES
Net Income -$23.13M -$36.31M
YoY Change -36.28% 86.43%
Depreciation, Depletion And Amortization $200.0K $100.0K
YoY Change 100.0% 150.0%
Cash From Operating Activities -$54.62M -$28.24M
YoY Change 93.41% 212.39%
INVESTING ACTIVITIES
Capital Expenditures -$590.0K -$1.250M
YoY Change -52.8% 1036.36%
Acquisitions
YoY Change
Other Investing Activities -$44.36M $46.82M
YoY Change -194.75% -426.5%
Cash From Investing Activities -$44.96M $45.57M
YoY Change -198.66% -415.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 63.79M 2.330M
YoY Change 2637.77% -83.3%
NET CHANGE
Cash From Operating Activities -54.62M -28.24M
Cash From Investing Activities -44.96M 45.57M
Cash From Financing Activities 63.79M 2.330M
Net Change In Cash -35.79M 19.66M
YoY Change -282.04% -305.86%
FREE CASH FLOW
Cash From Operating Activities -$54.62M -$28.24M
Capital Expenditures -$590.0K -$1.250M
Free Cash Flow -$54.03M -$26.99M
YoY Change 100.19% 202.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
33823000
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38615709
CY2017Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
194000
CY2016Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
2480000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
115321000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
27000
CY2016Q4 us-gaap Liabilities
Liabilities
232096000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
0
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
365298000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-42000
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
175000000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38615709
us-gaap License And Services Revenue
LicenseAndServicesRevenue
90668000
CY2017Q3 us-gaap License And Services Revenue
LicenseAndServicesRevenue
41283000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
204000
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31238000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
162511000
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4944000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-36308000
us-gaap Net Income Loss
NetIncomeLoss
-89194000
us-gaap Investment Income Interest
InvestmentIncomeInterest
722000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-191000
us-gaap Net Income Loss
NetIncomeLoss
-97885000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
420000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
172000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-306000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
3413000
us-gaap Increase Decrease In Unbilled Receivables
IncreaseDecreaseInUnbilledReceivables
-33542000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1263000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
4000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6666000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6196000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-8834000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
8017000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
8443000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
40000000
akba Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
347000
akba Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
2193000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-39781000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-37764000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1172000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2614000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
97868000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
125151000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
265648000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
132138000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-168952000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-9601000
akba Proceeds From Issuance Of Common Stock Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts
109541000
akba Proceeds From Issuance Of Common Stock Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockNetOfIssuanceCosts
63205000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
352000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
106000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1108000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
125000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
4000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
19000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
110997000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
63417000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-97736000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
16052000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49778000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65830000
akba Deferred Follow On Offering Issuance Costs
DeferredFollowOnOfferingIssuanceCosts
65000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Concentrations of Credit Risk and Off-Balance Sheet Risk </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash and investments are the only financial instruments that potentially subject the Company to concentrations of credit risk. The Company maintains its cash with high quality, accredited financial institutions and, accordingly, such funds are subject to minimal credit risk. The Company has no significant off-balance sheet concentrations of credit risk, such as foreign currency exchange contracts, option contracts or other hedging arrangements.</p></div>
CY2017Q3 akba Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
329705000
CY2017Q3 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2017Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4226000
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
862000
CY2017Q3 us-gaap Depreciation
Depreciation
200000
CY2016Q3 us-gaap Depreciation
Depreciation
100000
us-gaap Depreciation
Depreciation
400000
CY2017Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
240288000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies and controls, and in developing the estimates and assumptions that are used in the preparation of these financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including: expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. The estimation process often may yield a range of potentially reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. Estimates are used in the following areas, among others: prepaid and accrued research and development expense, stock-based compensation expense, revenue and income taxes. </p></div>
akba Operating Plan Sufficiently Funded By Cash Resources Period
OperatingPlanSufficientlyFundedByCashResourcesPeriod
P12M
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2016Q3 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3054000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
442000
us-gaap Depreciation
Depreciation
200000
akba Number Of Accounting Units
NumberOfAccountingUnits
3
CY2016 akba Cost Share Payment Received For License Agreement
CostSharePaymentReceivedForLicenseAgreement
33800000
CY2017Q3 akba Operating Leases Future Minimum Sublease Rental Income Due In Two Years
OperatingLeasesFutureMinimumSubleaseRentalIncomeDueInTwoYears
257000
CY2017Q3 akba Operating Leases Net Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesNetFutureMinimumPaymentsRemainderOfFiscalYear
822000
CY2016Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
596000
CY2017Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2279000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1975000
akba Sublease Term
SubleaseTerm
P2Y
akba Frequency Of Sublease Rent Receivable
FrequencyOfSubleaseRentReceivable
monthly
us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
22000
CY2017Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
6636779
CY2016Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
5268127
CY2017Q3 akba Allocated Share Based Compensation Expense Reversal
AllocatedShareBasedCompensationExpenseReversal
2153000
CY2016Q3 akba Allocated Share Based Compensation Expense Reversal
AllocatedShareBasedCompensationExpenseReversal
1628000
akba Allocated Share Based Compensation Expense Reversal
AllocatedShareBasedCompensationExpenseReversal
10087000
akba Allocated Share Based Compensation Expense Reversal
AllocatedShareBasedCompensationExpenseReversal
4101000
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
45362
us-gaap Operating Leases Rent Expense Minimum Rentals
OperatingLeasesRentExpenseMinimumRentals
242000
akba Operating Lease Payments Commencement Date
OperatingLeasePaymentsCommencementDate
2017-01-01
CY2017Q3 us-gaap Incentive From Lessor
IncentiveFromLessor
2169920
CY2017Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
70526
CY2017Q3 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
3384
CY2017Q1 akba Estimate Subsequent Cost Share Payment Receivable
EstimateSubsequentCostSharePaymentReceivable
153600000
akba Allocated Arrangement Consideration Under License Agreement
AllocatedArrangementConsiderationUnderLicenseAgreement
312400000
akba Milestone Payment Received
MilestonePaymentReceived
236700000
CY2017Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2000
CY2017Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
184000
CY2017Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
89599000
CY2017Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
329887000
CY2016Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
73048000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
40000
CY2016Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
187335000
CY2016Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
260383000
CY2016Q4 akba Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
260343000
CY2017Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
217429000
CY2017Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
22677000
CY2017Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
240106000
CY2017Q3 akba Accrued Clinical Expenses Current
AccruedClinicalExpensesCurrent
13977000
CY2016Q4 akba Accrued Clinical Expenses Current
AccruedClinicalExpensesCurrent
23643000
CY2017Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2403000
CY2016Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2995000
CY2017Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1541000
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
539000
CY2017Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
691000
CY2016Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
513000
CY2017Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
536000
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals
321000
akba Term For Security Deposit From Execution Of Sublease
TermForSecurityDepositFromExecutionOfSublease
P30D
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
886000
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3545000
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
3545000
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
3545000
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
3510000
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
14666000
CY2017Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
29697000
CY2017Q3 akba Operating Leases Future Minimum Sublease Rental Income Remainder Of Fiscal Year
OperatingLeasesFutureMinimumSubleaseRentalIncomeRemainderOfFiscalYear
64000
CY2017Q3 akba Operating Leases Net Future Minimum Payments Due In Two Years
OperatingLeasesNetFutureMinimumPaymentsDueInTwoYears
3288000
CY2017Q3 akba Operating Leases Net Future Minimum Payments Due In Three Years
OperatingLeasesNetFutureMinimumPaymentsDueInThreeYears
3545000
CY2017Q3 akba Operating Leases Net Future Minimum Payments Due In Four Years
OperatingLeasesNetFutureMinimumPaymentsDueInFourYears
3545000
CY2017Q3 akba Operating Leases Net Future Minimum Payments Due In Five Years
OperatingLeasesNetFutureMinimumPaymentsDueInFiveYears
3510000
CY2017Q3 akba Operating Leases Net Future Minimum Payments Due Thereafter
OperatingLeasesNetFutureMinimumPaymentsDueThereafter
14666000
CY2017Q3 akba Operating Leases Net Future Minimum Payments Due
OperatingLeasesNetFutureMinimumPaymentsDue
29376000
CY2017Q3 us-gaap Capital Leases Future Minimum Payments Remainder Of Fiscal Year
CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear
2000
CY2017Q3 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
5000
CY2017Q3 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
7000
CY2017Q3 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
7000
CY2017Q3 us-gaap Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year
ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear
824000
CY2017Q3 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
3293000
CY2017Q3 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
3545000
CY2017Q3 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
3545000
CY2017Q3 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
3510000
CY2017Q3 us-gaap Contractual Obligation Due After Fifth Year
ContractualObligationDueAfterFifthYear
14666000
CY2017Q3 us-gaap Contractual Obligation
ContractualObligation
29383000
CY2017Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
800000
CY2016Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
600000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2400000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1700000
us-gaap Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross
ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
43800000
CY2016 us-gaap Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross
ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross
24900000
CY2017Q3 akba Purchase Committed Program Remaining Contract Costs
PurchaseCommittedProgramRemainingContractCosts
293800000
CY2017Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
27000
CY2016Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
21000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
200000
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
100000
akba Defined Contribution Plan Employees Age To Be Eligible Under Plan
DefinedContributionPlanEmployeesAgeToBeEligibleUnderPlan
P21Y
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4995334
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3549288

Files In Submission

Name View Source Status
0001564590-17-022727-index-headers.html Edgar Link pending
0001564590-17-022727-index.html Edgar Link pending
0001564590-17-022727.txt Edgar Link pending
0001564590-17-022727-xbrl.zip Edgar Link pending
akba-10q_20170930.htm Edgar Link pending
akba-20170930.xml Edgar Link completed
akba-20170930.xsd Edgar Link pending
akba-20170930_cal.xml Edgar Link unprocessable
akba-20170930_def.xml Edgar Link unprocessable
akba-20170930_lab.xml Edgar Link unprocessable
akba-20170930_pre.xml Edgar Link unprocessable
akba-ex101_154.htm Edgar Link pending
akba-ex311_12.htm Edgar Link pending
akba-ex312_10.htm Edgar Link pending
akba-ex321_6.htm Edgar Link pending
akba-ex991_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g20171108134205712971.jpg Edgar Link pending
g20171108134205989972.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending